Standard BioTools, Inc. (LAB)
0.9967
+0.01
(+0.77%)
USD |
NASDAQ |
May 19, 16:00
0.9967
0.00 (0.00%)
After-Hours: 19:25
Standard BioTools Research and Development Expense (Quarterly) : 2.117M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Rapid Micro Biosystems, Inc. | 3.359M |
| Cytek Biosciences, Inc. | 9.604M |
| Henry Schein, Inc. | -- |
| Accendra Health, Inc. | -- |
| Itonis, Inc. | -- |